Partida Corona Medical Center
-
Services:
- Individual counseling
- Smoking/vaping/tobacco cessation counseling
- Health education services other than HIV/AIDS or hepatitis
- Hepatitis education, counseling, or support
- HIV or AIDS education, counseling, or support
- Substance use disorder education
- State Substance use treatment agency
- Buprenorphine without naloxone
- Medications for pre-exposure to prophylaxis
- Non-nicotine smoking/tobacco cessation
- Medications for Hepatitis C treatment
- Medication for mental disorders
- Medications for HIV treatment
- Buprenorphine with naloxone
- Acamprosate (Campral®)
- Naltrexone (oral)
- Clonidine
- Disulfiram
- Naltrexone (extended-release, injectable)
- Buprenorphine (extended-release, injectable)
- Nicotine replacement
- No formal relationship with prescribing entity
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Private for-profit organization
- Male
- Female
- Mental health services
- Early intervention for HIV
- Social skills development
- Domestic violence services, including family or partner
- Integrated primary care services
- Smoking not permitted
- No formal relationship with prescribing entity
- Cash or self-payment
- IHS/Tribal/Urban (ITU) funds
- Private health insurance
- Federal military insurance (e.g., TRICARE)
- State-financed health insurance plan other than Medicaid
- Medicaid
- Medicare
- SAMHSA funding/block grants
- Children/Adolescents
- Relapse prevention with naltrexone
- Lofexidine or Clonidine detoxification
- Accepts clients using MAT but prescribed elsewhere
- Prescribes buprenorphine
- Buprenorphine detoxification
- Maintenance service with medically supervised withdrawal after stabilization
- Buprenorphine maintenance
- Prescribes naltrexone
- Opioids detoxification
- Alcohol Detoxification
- Cocaine Detoxification
- Medication routinely used during detoxification
- Benzodiazepines Detoxification
- Methamphetamines detoxification
- Aftercare/continuing care
- Discharge Planning
- Outcome follow-up after discharge
- Naloxone and overdose education
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Substance use treatment
- Detoxification
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Cognitive behavioral therapy
- Substance use disorder counseling
- Anger management
- Telemedicine/telehealth therapy
- Trauma-related counseling
- Contingency management/motivational incentives
- Brief intervention
- Relapse prevention
- Motivational interviewing
- Vaping not permitted
- HIV testing
- Drug or alcohol urine screening
- TB screening
- Testing for Hepatitis B (HBV)
- Metabolic syndrome monitoring
- Testing for Hepatitis C (HCV)
- STD testing
- Outreach to persons in the community
- Comprehensive substance use assessment
- Screening for tobacco use
- Professional interventionist/educational consultant
- Comprehensive mental health assessment
- Screening for mental disorders
- Screening for substance use
- Complete medical history/physical exam
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient detoxification
- Outpatient
Education and Counseling Services
License/Certification/Accreditation
Pharmacotherapies
External Opioid Medications Source
Type of Alcohol Use Disorder Treatment
Facility Operation (e.g., Private, Public)
Gender Accepted
Ancillary Services
Facility Smoking Policy
External Source of Medications Used for Alcohol Use Disorder Treatment
Payment/Insurance/Funding Accepted
Age Groups Accepted
Type of Opioid Treatment
Detoxification (medical withdrawal) Services
Transitional Services
Opioid Medications used in Treatment
Type of Care
Treatment Approaches
Facility Vaping Policy
Testing
Assessment/Pre-treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)